Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Have you been told you have a condition called ‘Avascular Necrosis’ or ‘Osteonecrosis’? If so, could we talk to you about a new study that is currently being thought about?

Who are we?

We are a team of university researchers, surgeons, rheumatologists and nurses wanting to investigate which drugs might better help people with ‘Avascular Necrosis’ or ‘Osteonecrosis’. 

Who are we looking for?

The National Institute for Health Research is looking to fund a study to decide if one drug or a combination of drugs might improve pain and movement for individuals with these painful conditions.

We would like to invite people who have experienced hip pain due to the above conditions to join us for an informal meeting to talk about the proposed study, and to ask your opinions about the study we are thinking we would run – YOU WOULD NOT BE JOINING OR BE ASKED TO JOIN THE STUDY.

Want to learn more?

Join us for a meeting on Friday 4th September in Oxford at the Botnar Research Centre at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences. We will provide light refreshments and will reimburse you for your time and travel.

If you are interested in knowing more and would like to get involved, please call Vicki Barber on  01865 223463 or email                                                   

This study is supported by the Patient and Public Involvement Officer, Research Design Service South Central, National Institute for Health Research.

Similar stories

Clinical trial finds Azithromycin has no benefit against COVID-19


A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.

Study reveals the three most important aspects of care for hip fractures

Hip Main OCTRU Research Trauma

Older patients with hip fractures recover better if they receive treatment under the supervision of both a surgeon and a specialist in elderly care; are checked to avoid future falls; and are assessed for memory problems.

AVID-CC trial opens to recruitment!


The AVID-CC trial has received OCTRU Green Light approval and is now open to recruitment!

WHiTE Four trial results published

Hip Main OCTRU Orthopaedics and trauma Research Trauma

The results of the WHiTE Four clinical trial for the treatment of fragility hip fractures have been published in The Bone and Joint Journal.

WHiTE Four trial results!


The WHiTE Four trial has now published its results in The Bone & Joint journal.

FUTURE GB Trial opens to recruitment!


The FUTURE GB Trial has received OCTRU Green Light approval and is now open to recruitment!